Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05093322
Title A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hutchison Medipharma Limited
Indications

rhabdomyosarcoma

osteosarcoma

Ewing sarcoma

sarcoma

lymphoma

Advanced Solid Tumor

Therapies

Gemcitabine + Surufatinib

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.